FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3022990620> ?p ?o ?g. }

• W3022990620 endingPage "4345" @default.
• W3022990620 startingPage "4336" @default.
• W3022990620 abstract "Abstract HIV infection is characterized by chronic immune activation and the establishment of a pool of latently infected cells. Antiretroviral therapy (ART) can suppress viral load to undetectable levels in peripheral blood by standard measure, however immune activation/chronic inflammation and latent infection persist and affect quality of life. We have now shown that a novel therapeutic HIV vaccine consisting of replication-defective HIV (HIVAX), given in the context of viral suppression under ART, can reduce both immune activation/chronic inflammation and latent infection. Immune activation, as measured by percent of CD8 + HLA-DR + CD38 + T cells, approached levels of healthy controls at week 16 following vaccination. Reduced immune activation was accompanied by a reduction in pro-inflammatory cytokines and peripheral α4β7 + plasmacytoid DC (a marker of mucosal immune activation). Levels of both HIV-1 DNA and 2-LTR circles were reduced at week 16 following vaccination, suggesting HIVAX can impact HIV-1 latency and reduce viral replication. Surprisingly, reduced immune activation/chronic inflammation was accompanied by an increase in the percent of memory CD4 + T cells expressing markers PD-1 and TIM-3. In addition, evaluation of HIV-1 Gag-specific CD4 + T cells for expression of 96 T cell related genes pre- and post-therapy revealed increased expression of a number of genes involved in the regulation of immune activation, T cell activation, and antiviral responses. Overall this study provides evidence that vaccination with HIVAX in subjects under long term antiviral suppression can reduce immune activation/chronic inflammation and latent infection (Clinicaltrials.gov, identifier NCT01428596)." @default.
• W3022990620 created "2020-05-13" @default.
• W3022990620 creator A5002278563 @default.
• W3022990620 creator A5024777848 @default.
• W3022990620 creator A5025834447 @default.
• W3022990620 creator A5026274902 @default.
• W3022990620 creator A5028861349 @default.
• W3022990620 creator A5036809089 @default.
• W3022990620 creator A5039963706 @default.
• W3022990620 creator A5050254856 @default.
• W3022990620 creator A5055856047 @default.
• W3022990620 creator A5060567703 @default.
• W3022990620 creator A5063343955 @default.
• W3022990620 creator A5065148141 @default.
• W3022990620 creator A5084232309 @default.
• W3022990620 date "2020-06-01" @default.
• W3022990620 modified "2023-10-14" @default.
• W3022990620 title "A therapeutic HIV-1 vaccine reduces markers of systemic immune activation and latent infection in patients under highly active antiretroviral therapy" @default.
• W3022990620 cites W1512110864 @default.
• W3022990620 cites W1932046647 @default.
• W3022990620 cites W1964918056 @default.
• W3022990620 cites W1975976447 @default.
• W3022990620 cites W1978436252 @default.
• W3022990620 cites W1982595765 @default.
• W3022990620 cites W2008221016 @default.
• W3022990620 cites W2016844693 @default.
• W3022990620 cites W2025952153 @default.
• W3022990620 cites W2027422101 @default.
• W3022990620 cites W2035951788 @default.
• W3022990620 cites W2041083195 @default.
• W3022990620 cites W2057100102 @default.
• W3022990620 cites W2062274686 @default.
• W3022990620 cites W2063793430 @default.
• W3022990620 cites W2065172977 @default.
• W3022990620 cites W2066409312 @default.
• W3022990620 cites W2072661867 @default.
• W3022990620 cites W2072834778 @default.
• W3022990620 cites W2084038115 @default.
• W3022990620 cites W2086014112 @default.
• W3022990620 cites W2098849961 @default.
• W3022990620 cites W2102433466 @default.
• W3022990620 cites W2104439840 @default.
• W3022990620 cites W2112806309 @default.
• W3022990620 cites W2119896120 @default.
• W3022990620 cites W2122483069 @default.
• W3022990620 cites W2126076752 @default.
• W3022990620 cites W2127031590 @default.
• W3022990620 cites W2128122026 @default.
• W3022990620 cites W2131142211 @default.
• W3022990620 cites W2132813747 @default.
• W3022990620 cites W2132838609 @default.
• W3022990620 cites W2139250164 @default.
• W3022990620 cites W2140573695 @default.
• W3022990620 cites W2143549358 @default.
• W3022990620 cites W2145476394 @default.
• W3022990620 cites W2153136696 @default.
• W3022990620 cites W2252542195 @default.
• W3022990620 cites W2255978246 @default.
• W3022990620 cites W2275979138 @default.
• W3022990620 cites W2309734431 @default.
• W3022990620 cites W2404185225 @default.
• W3022990620 cites W2409723445 @default.
• W3022990620 cites W2432649889 @default.
• W3022990620 cites W2514207301 @default.
• W3022990620 cites W2531567355 @default.
• W3022990620 cites W2553193756 @default.
• W3022990620 cites W2558845878 @default.
• W3022990620 cites W2793169449 @default.
• W3022990620 cites W2794196642 @default.
• W3022990620 cites W2948963940 @default.
• W3022990620 cites W4210975044 @default.
• W3022990620 doi "https://doi.org/10.1016/j.vaccine.2020.04.015" @default.
• W3022990620 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32387010" @default.
• W3022990620 hasPublicationYear "2020" @default.
• W3022990620 type Work @default.
• W3022990620 sameAs 3022990620 @default.
• W3022990620 citedByCount "4" @default.
• W3022990620 countsByYear W30229906202021 @default.
• W3022990620 countsByYear W30229906202022 @default.
• W3022990620 countsByYear W30229906202023 @default.
• W3022990620 crossrefType "journal-article" @default.
• W3022990620 hasAuthorship W3022990620A5002278563 @default.
• W3022990620 hasAuthorship W3022990620A5024777848 @default.
• W3022990620 hasAuthorship W3022990620A5025834447 @default.
• W3022990620 hasAuthorship W3022990620A5026274902 @default.
• W3022990620 hasAuthorship W3022990620A5028861349 @default.
• W3022990620 hasAuthorship W3022990620A5036809089 @default.
• W3022990620 hasAuthorship W3022990620A5039963706 @default.
• W3022990620 hasAuthorship W3022990620A5050254856 @default.
• W3022990620 hasAuthorship W3022990620A5055856047 @default.
• W3022990620 hasAuthorship W3022990620A5060567703 @default.
• W3022990620 hasAuthorship W3022990620A5063343955 @default.
• W3022990620 hasAuthorship W3022990620A5065148141 @default.
• W3022990620 hasAuthorship W3022990620A5084232309 @default.
• W3022990620 hasConcept C142462285 @default.
• W3022990620 hasConcept C159047783 @default.
• W3022990620 hasConcept C203014093 @default.
• W3022990620 hasConcept C2779690655 @default.

• next